These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model. Yao X; Carlson D; Sun Y; Ma L; Wolf SE; Minei JP; Zang QS PLoS One; 2015; 10(10):e0139416. PubMed ID: 26448624 [TBL] [Abstract][Full Text] [Related]
43. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge. Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479 [TBL] [Abstract][Full Text] [Related]
44. Inflammatory mediators are inhibited by a taurine metabolite in CpG oligodeoxynucleotide and IFN-r activated macrophage cell line. Kim BS; Spinner DS; Kascsak RJ; Park SY; Cho IS; Schuller-Levis G; Park E J Drugs Dermatol; 2013 May; 12(5):551-7. PubMed ID: 23652950 [TBL] [Abstract][Full Text] [Related]
45. Ammonia-Induced Brain Edema Requires Macrophage and T Cell Expression of Toll-Like Receptor 9. Manakkat Vijay GK; Hu C; Peng J; Garcia-Martinez I; Hoque R; Verghis RM; Ma Y; Mehal WZ; Shawcross DL; Wen L Cell Mol Gastroenterol Hepatol; 2019; 8(4):609-623. PubMed ID: 31401214 [TBL] [Abstract][Full Text] [Related]
46. Functional expression of TLR9 in esophageal cancer. Zhang Y; Wang Q; Ma A; Li Y; Li R; Wang Y Oncol Rep; 2014 May; 31(5):2298-304. PubMed ID: 24647486 [TBL] [Abstract][Full Text] [Related]
47. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Ivanov S; Dragoi AM; Wang X; Dallacosta C; Louten J; Musco G; Sitia G; Yap GS; Wan Y; Biron CA; Bianchi ME; Wang H; Chu WM Blood; 2007 Sep; 110(6):1970-81. PubMed ID: 17548579 [TBL] [Abstract][Full Text] [Related]
48. Protective effects of astragalus polysaccharide nanoparticles on septic cardiac dysfunction through inhibition of TLR4/NF-κB signaling pathway. Xu X; Rui S; Chen C; Zhang G; Li Z; Wang J; Luo Y; Zhu H; Ma X Int J Biol Macromol; 2020 Jun; 153():977-985. PubMed ID: 31760017 [TBL] [Abstract][Full Text] [Related]
49. Evidence of an anti-inflammatory toll-like receptor 9 (TLR 9) pathway in adipocytes. Thomalla M; Schmid A; Neumann E; Pfefferle PI; Müller-Ladner U; Schäffler A; Karrasch T J Endocrinol; 2019 Feb; 240(2):325-343. PubMed ID: 30508414 [TBL] [Abstract][Full Text] [Related]
50. An oligodeoxynucleotide with CCT repeats restrains CpG ODN-induced TLR9 trafficking. Zhang X; Sun W; Wu X; Wang H; Yan Y; Guo S; Song D; Li H; Gao S; Wang L; Yu Y; Wang L Curr Pharm Biotechnol; 2014; 15(9):780-9. PubMed ID: 25374030 [TBL] [Abstract][Full Text] [Related]
51. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503 [TBL] [Abstract][Full Text] [Related]
52. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners. Ma C; Spies NP; Gong T; Jones CX; Chu WM PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014 [TBL] [Abstract][Full Text] [Related]
53. Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo. Klaschik S; Tross D; Klinman DM J Leukoc Biol; 2009 May; 85(5):788-95. PubMed ID: 19179452 [TBL] [Abstract][Full Text] [Related]
54. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity. Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053 [TBL] [Abstract][Full Text] [Related]
55. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Mohamed FE; Al-Jehani RM; Minogue SS; Andreola F; Winstanley A; Olde Damink SW; Habtesion A; Malagó M; Davies N; Luong TV; Dhillon AP; Mookerjee RP; Dhar DK; Jalan R Liver Int; 2015 Mar; 35(3):1063-76. PubMed ID: 24990399 [TBL] [Abstract][Full Text] [Related]
56. Role of Toll-like receptor 9 signaling on activation of nasal polyp-derived fibroblasts and its association with nasal polypogenesis. Park SK; Jin SY; Yeon SH; Lee SB; Xu J; Yoon YH; Rha KS; Kim YM Int Forum Allergy Rhinol; 2018 Sep; 8(9):1001-1012. PubMed ID: 29901280 [TBL] [Abstract][Full Text] [Related]
58. CpG-ODN exerts a neuroprotective effect via the TLR9/pAMPK signaling pathway by activation of autophagy in a neonatal HIE rat model. Ye L; Feng Z; Doycheva D; Malaguit J; Dixon B; Xu N; Zhang JH; Tang J Exp Neurol; 2018 Mar; 301(Pt A):70-80. PubMed ID: 29274721 [TBL] [Abstract][Full Text] [Related]
59. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Miura K; Kodama Y; Inokuchi S; Schnabl B; Aoyama T; Ohnishi H; Olefsky JM; Brenner DA; Seki E Gastroenterology; 2010 Jul; 139(1):323-34.e7. PubMed ID: 20347818 [TBL] [Abstract][Full Text] [Related]
60. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells. Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]